The Future is Now: How Adult Stem Cell Treatment is Transforming Medicine The field of stem cell research has quickly reached a magnitude that it continues to elude the understanding of all but the most advanced of the scientific community. Many people are unaware that the first successful stem cell transplant occurred more … Continue reading
Britain’s gene therapy industry has taken a step forward with a medicine that may help cure brain cancer moving closer to receiving regulatory approval. Ark Therapeutics, maker of Cerepro – which helps to stop cancer returning to the brain after a tumour is removed through an operation – yesterday said it had successfully manufactured a … Continue reading
IT WAS the kind of breakthrough scientists had dreamed of for decades and its promise to help cure disease appears to be fast on the way to being realised. Researchers in November announced they were able to turn the clock back on skin cells and transform them into stem cells, the mutable building blocks of … Continue reading
British researchers say they had succeeded in reprogramming amniotic fluid cells without having to introduce extra genes. This suggests the possibility that stem cells derived from donated amniotic fluid could be stored in banks and used for medical therapies and in research, offering a less problematic alternative to embryonic stem cells. Stem cells are the … Continue reading
KIRKLAND, Wash., Nov. 9 /PRNewswire-FirstCall/ — CellCyte Genetics Corporation (OTC Bulletin Board: CCYG) announced today that is has received notice of the issuance of a U.S. patent (U.S. Patent No. 7,282,222) for its unique methods and compositions approach to deliver and direct stem cells to target organs in the body. Using this now-patented technology, exclusively … Continue reading
A new collaboration has begun between the largest European family adult stem cell bank, Cryo-Save, and Europe’s most important Catholic university, “Università Cattolica del Sacro Cuore” (UCSC). Policlinico “Gemelli” University Hospital based in Rome, Italy, is part of the UCSC Faculty of Medicine and Surgery and is owned by the Vatican. The partnership aims at … Continue reading
dailyfinance.com 2010-04-13 For investors on the hunt for groundbreaking technologies, stem cell therapies originally looked promising. But the world has been waiting for a long time for the basic research to transform into viable therapies, and in the meantime, Wall Street has largely lost interest. Now, however, there’s a “disconnect between science and valuation in … Continue reading